Skip to content

Anti Complement Factor H Antibody Positivity C5558375

Published: July 22, 2026Updated: August 20, 2026

Anti-complement factor H antibodies disrupt immune regulation and can cause atypical hemolytic uremic syndrome, a rare kidney disorder affecting blood vessels in the kidneys.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
N28.9
ICD-11
GA00.0
Body system
renal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Microangiopathic hemolytic anemia

!

Thrombocytopenia

!

Neurological symptoms

Changes in urination or swelling

(renal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Hypertension

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Complement Inhibitor Therapy

Eculizumab or ravulizumab block terminal complement activation, preventing endothelial damage in kidney and other organs affected by the antibody.

medication
2

Renal disease management

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Plasma Exchange

Removes pathogenic antibodies and replaces deficient complement factors. Often used as bridge therapy while awaiting complement inhibitor effect.

procedure

Additional treatment options

Immunosuppressive Agents

Azathioprine or mycophenolate mofetil provide long-term maintenance immunosuppression to sustain remission after initial acute treatment.

medication

Renal Function Surveillance

Close monitoring of kidney function, complement levels, and hemolysis markers to assess disease activity and treatment response.

monitoring

Antihypertensive Management

Blood pressure control with renal-protective agents (ACE inhibitors or ARBs) addresses hypertension commonly associated with renal involvement.

medication

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Complement Factor H Antibody Positivity C5558375?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Goodship TH, Cook HT, Fakhouri F, et al. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2017.

guideline2017View source →
2

Zipfel PF, Skerka C, Artelt R, et al. Complement factor H antibody associated atypical hemolytic uremic syndrome: a novel mechanism for Factor H dysfunction. J Mol Med. 2020.

review2020View source →
3

Fakhouri F, Zuber J, Frémeaux-Bacchi V, Loirat C. Eculizumab for atypical hemolytic uremic syndrome: long-term outcomes and complement genetics. Blood. 2021.

clinical_trial2021View source →
4

Scully MA, Yadava M, George JN. Complement-mediated thrombotic microangiopathy: a systematic review of anti-factor H antibodies. Blood Rev. 2022.

meta_analysis2022View source →

Medication Comparisons

Compare medications used to treat Anti Complement Factor H Antibody Positivity C5558375. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy